Literature DB >> 10999960

Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U.

J A Hedrick1, K Morse, L Shan, X Qiao, L Pang, S Wang, T Laz, E L Gustafson, M Bayne, F J Monsma.   

Abstract

Neuromedin U (NmU) is a 25 amino acid peptide prominently expressed in the upper gastrointestinal (GI) tract and central nervous system. It is highly conserved throughout evolution and induces smooth muscle contraction in a variety of species. Our understanding of NmU biology has been limited because the identity of its receptor was unknown. Here we demonstrate that GPR66/FM-3 is specifically stimulated by NmU, causing the mobilization of intracellular calcium. This response was dose-dependent (EC(50) = 10 nM) and specific in that none of over 1000 ligands tested, including other neuromedins (NmB, C, L, K, N), induced a calcium flux in GPR66/FM-3-transfected cells. The GPR66/FM-3 mRNA is prominently expressed in the upper GI tract of humans, as is the mRNA for NmU, consistent with role for this receptor-ligand pair in regulating the function of this organ system. In addition, we show that whereas neuromedin U is expressed by monocytes and dendritic cells, GPR66/FM-3 is expressed by T cells and NK cells. These data suggest a previously unrecognized role for NmU as an immunoregulatory molecule.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999960     DOI: 10.1124/mol.58.4.870

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  27 in total

Review 1.  Novel neuropeptides as ligands of orphan G protein-coupled receptors.

Authors:  Yan Zhang; Zhiwei Wang; Gregory Scott Parks; Olivier Civelli
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Neuromedin U can exert colon-specific, enteric nerve-mediated prokinetic activity, via a pathway involving NMU1 receptor activation.

Authors:  N B Dass; A K Bassil; V J North-Laidler; R Morrow; E Aziz; B R Tuladhar; G J Sanger
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

4.  Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding.

Authors:  Hongkui Zeng; Alexander Gragerov; John G Hohmann; Maria N Pavlova; Brian A Schimpf; Hui Xu; Long-Jun Wu; Hiroki Toyoda; Ming-Gao Zhao; Alex D Rohde; Galina Gragerova; Rene Onrust; John E Bergmann; Min Zhuo; George A Gaitanaris
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

5.  Identification of neuromedin S and its possible role in the mammalian circadian oscillator system.

Authors:  Kenji Mori; Mikiya Miyazato; Takanori Ida; Noboru Murakami; Ryota Serino; Yoichi Ueta; Masayasu Kojima; Kenji Kangawa
Journal:  EMBO J       Date:  2005-01-06       Impact factor: 11.598

6.  The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.

Authors:  Antonia Wallrapp; Samantha J Riesenfeld; Patrick R Burkett; Raja-Elie E Abdulnour; Jackson Nyman; Danielle Dionne; Matan Hofree; Michael S Cuoco; Christopher Rodman; Daneyal Farouq; Brian J Haas; Timothy L Tickle; John J Trombetta; Pankaj Baral; Christoph S N Klose; Tanel Mahlakõiv; David Artis; Orit Rozenblatt-Rosen; Isaac M Chiu; Bruce D Levy; Monika S Kowalczyk; Aviv Regev; Vijay K Kuchroo
Journal:  Nature       Date:  2017-09-13       Impact factor: 49.962

Review 7.  Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.

Authors:  J D Mitchell; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

8.  Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats.

Authors:  Jane Gartlon; Philip Szekeres; Mark Pullen; Henry M Sarau; Nambi Aiyar; Usman Shabon; David Michalovich; Klaudia Steplewski; Cathy Ellis; Nabil Elshourbagy; Mark Duxon; Tracey E Ashmeade; David C Harrison; Paul Murdock; Shelagh Wilson; Abdel Ennaceur; Alan Atkins; Christian Heidbreder; Jim J Hagan; A Jackie Hunter; Declan N C Jones
Journal:  Psychopharmacology (Berl)       Date:  2004-06-16       Impact factor: 4.530

9.  The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).

Authors:  Andrea Peier; Jennifer Kosinski; Kimberly Cox-York; Ying Qian; Kunal Desai; Yue Feng; Prashant Trivedi; Nicholas Hastings; Donald J Marsh
Journal:  Endocrinology       Date:  2009-03-26       Impact factor: 4.736

10.  Species-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice.

Authors:  Clodagh E Prendergast; Magda F Morton; Katherine W Figueroa; Xiaodong Wu; Nigel P Shankley
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.